| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/28/2001 | WO2001046226A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046224A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046215A1 Process for the scaleable purification of plasmid dna |
| 06/28/2001 | WO2001046175A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | WO2001045752A1 Interventions to mimic the effects of calorie restriction |
| 06/28/2001 | WO2001045748A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 06/28/2001 | WO2001045746A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | WO2001045735A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001045728A2 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 06/28/2001 | WO2001045548A2 Surgical needle with weeping tip and method of use |
| 06/28/2001 | WO2001045522A1 The removal of extraneous substances from biological fluids containing nucleic acids and the recovery of nucleic acids |
| 06/28/2001 | WO2001045510A1 Adeno-associated vectors for expression of factor viii by target cells |
| 06/28/2001 | WO2001045500A1 A method to produce cloned embryos and adults from cultured cells |
| 06/28/2001 | WO2001045495A2 Potassium channel stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045494A2 Pyrophosphatase stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045493A2 Transcription factor stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045492A2 Protein kinase stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001040464A8 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/28/2001 | WO2001014402A8 Antisense modulation of focal adhesion kinase expression |
| 06/28/2001 | WO2001005974A9 The il-1l1 gene and polypeptide products |
| 06/28/2001 | WO2001005961B1 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
| 06/28/2001 | WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines |
| 06/28/2001 | WO2001003686A3 Inhibitors of staphylococcus sara protein and their use in treating staphylococcal infections |
| 06/28/2001 | WO2001002561A3 Mammalian calcium channels and related probes, cell lines and methods |
| 06/28/2001 | WO2000077186A3 Bacterial protection against stress |
| 06/28/2001 | WO2000076450A3 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 06/28/2001 | WO2000075359A3 Gene encoding short integuments and uses thereof |
| 06/28/2001 | WO2000075324A3 Recombinant prion-like genes and proteins and materials and methods comprising same |
| 06/28/2001 | WO2000075305A3 Candida albicans genes and proteins coded by said genes |
| 06/28/2001 | WO2000073462A3 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 06/28/2001 | WO2000073452A3 Compositions and methods for the treatment of immune related diseases |
| 06/28/2001 | WO2000073446A3 Adipocyte complement related protein homolog zacrp6 |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000071741A3 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 06/28/2001 | WO2000071725A3 Combination neisserial compositions |
| 06/28/2001 | WO2000070342A3 Optical system analysis of cells |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000061814A9 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
| 06/28/2001 | WO2000060079A3 New members of tnf and tnfr families |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000053744A9 End selection in directed evolution |
| 06/28/2001 | WO2000044774A3 Inhibition of stat3 signal transduction for human cancer therapy |
| 06/28/2001 | WO2000037683B1 HIGH THROUGHPUT ASSAY SYSTEM FOR MONITORING ESTs |
| 06/28/2001 | WO2000027437A9 Polymer grafting by polysaccharide synthases |
| 06/28/2001 | WO2000004040A9 Constitutive disease resistance gene (cdr1), and methods of use thereof |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | WO1997046686A3 Tumor necrosis factor-related polypeptide |
| 06/28/2001 | WO1997039029A3 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
| 06/28/2001 | US20010005749 Aromatic amino acid catabolism enzymes |
| 06/28/2001 | US20010005746 Stomatin-like genes and their use in plants |
| 06/28/2001 | US20010005717 Gene transfer complexes of a polyethyleneimine having a hydrophilic polymer such as polyoxyethylene glycol coupled thereto, and a nucleic acid; use in gene therapy |
| 06/28/2001 | US20010005589 A DNA having promoter activity of Tec tyrosine kinase and a vector incoporating the promoter to obtain a high level of expression of an exogenous gene in hematopoietic stem cells and hepatic cells; gene therapy |
| 06/28/2001 | US20010005588 A solid carrier where nucleotides are fixed by covalent bonding by a reaction of a reactive group on the carrier and a reactive group on the nucleotide using a transition metal catalyst; no blocking procedure; hydbridization; |
| 06/28/2001 | US20010005586 High speed selective identification, indivisual targeting with an energy beam, specific cells within a cell population for the purpose of inducing a response in the targeted cells, without affecting cells that are not being targeted |
| 06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
| 06/28/2001 | DE19962409A1 Nucleic acid encoding delta6-acetylenase or desaturase, useful for producing plant oils with increased content of unsaturated fatty acids |
| 06/28/2001 | DE19960843A1 Wurzelspezifischer Promotor Root-specific promoter |
| 06/28/2001 | DE19959857C1 Testsystem zum Nachweis von Analyten sowie ein Verfahren zur Herstellung und Verwendung Test system for detection of analytes and a method of making and using |
| 06/28/2001 | DE19959045A1 Adeno-associated virus vectors that express monocyte chemotactic protein-1, useful for gene therapy of cancers, promotion of angiogenesis and treatment of inflammation |
| 06/28/2001 | DE19958961A1 New plant nucleic acid transcribed quickly after pathogen infection, useful e.g. for increasing pathogen resistance of crops, especially potatoes against Phytophthora infestans |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | DE19953854A1 Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften A process for the production of biopolymers with modified properties |
| 06/28/2001 | DE10036175A1 Determining activity of nucleic acid, useful for optimizing therapeutic or diagnostic nucleic acids, by transforming organisms, in parallel, with many different sequences |
| 06/28/2001 | DE10027954A1 Humanes Procalcitonin, dessen Herstellung und Verwendung Human procalcitonin, its preparation and use |
| 06/28/2001 | CA2396677A1 Inhibition of cellular proteases |
| 06/28/2001 | CA2395714A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | CA2395578A1 Replication incompetent herpes virus vectors |
| 06/28/2001 | CA2395576A1 Replication incompetent herpes viruses for use in gene therapy |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395466A1 Interventions to mimic the effects of calorie restriction |
| 06/28/2001 | CA2395429A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 06/28/2001 | CA2395406A1 Method for treating inflammation |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395286A1 Aspartyl proteases |
| 06/28/2001 | CA2395269A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | CA2395247A1 Novel human membrane proteins and polynucleotides encoding the same |
| 06/28/2001 | CA2395239A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |
| 06/28/2001 | CA2395228A1 Pathologically modified myocardial cell, production and use thereof |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395208A1 Nucleic acid vaccination |
| 06/28/2001 | CA2395102A1 Human kinases |
| 06/28/2001 | CA2395093A1 Mammalian protein phosphatases |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394974A1 Method of nucleic acid detection using target-specific assays |
| 06/28/2001 | CA2394860A1 Hypodermic needle with weeping tip and method of use |
| 06/28/2001 | CA2394812A1 A method to produce cloned embryos and adults from cultured cells |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394759A1 Gibberellin 3.beta.-hydroxylase of rice and uses thereof |
| 06/28/2001 | CA2394757A1 Novel gene and use thereof |
| 06/28/2001 | CA2394743A1 Inhibition of .beta.arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |